Search results
Author(s):
Katrina Mountfort
,
Karl-Heinz Kuck
,
Richard Schilling
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased risk of stroke, heart failure and mortality.1 Following increased therapeutic options for AF, an update in guidelines for management of AF has been published. A symposium, chaired by Karl- Heinz Kuck, Hamburg, Germany, was held at the European Society of Cardiology (ESC) congress in Paris on the 2nd September…
View more
Dual Antiplatelet Therapy in CAD
Author(s):
Christopher N Floyd
Added:
3 years ago
Article
Author(s):
V Blaha
,
R Margoczy
,
I Petrov
,
et al
Added:
11 months ago
Author(s):
David Calvo Cuervo
Added:
1 year ago
Author(s):
Jose A Joglar
Added:
2 months ago
Dr Jose Joglar (UT Southwestern, US) joins us virtually to discuss the 2023 guidelines for atrial fibrillation (AF) diagnosis and management.These guidelines are an update to the 2014 document covering the full spectrum of managing patients with AF, from prevention to lifetime interventions, to rhythm and rate control, as well as special populations. A new classification of AF has been created,…
View more
Ankur Kalra
Research Area(s) / Expertise:
Author
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the hot line and late-breaking trials that will be presented atESC Congress 2021.
What presentations should we look out for this weekend? Get your update on the importance of trials such as GUIDE-HF, MASTER DAPT, TOMAHAWK…
View more
Foreword
Author(s):
Pasquale Perrone-Filardi
Added:
3 years ago
Article
Author(s):
Gregg C Fonarow
,
Tariq Ahmad
,
Harriette Van Spall
Added:
1 year ago
Dr Harriette Van Spall (McMaster University, CA) talked with Dr Gregg C Fonarow (University of California, US) and Dr Tariq Ahmad (Yale School of Medicine, US) about the PROMPT-HF trial (NCT04514458) presented first at ACC.22.
PROMPT-HF compared the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care in outpatient…
View more
Author(s):
Harriette Van Spall
,
John Spertus
Added:
2 years ago
Late-breaker host Dr Harriette Van Spall (McMaster University, CA) invites PI, Dr John Spertus to discuss the innovative CHIEF-HF clinical trial.
The aim of this study was to determine the superiority of the effectiveness of canagliflozin versus placebo in participants with symptomatic heart failure (HF) in improving the overall Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score …
View more